TY - JOUR
T1 - Expanding the phenotype of TAB2 variants and literature review
AU - Woods, Emily
AU - Marson, Imogen
AU - Coci, Emanuele
AU - Spiller, Michael
AU - Kumar, Ajith
AU - Brady, Angela
AU - Homfray, Tessa
AU - Fisher, Richard
AU - Turnpenny, Peter
AU - Rankin, Julia
AU - Kanani, Farah
AU - Platzer, Konrad
AU - Ververi, Athina
AU - Emmanouilidou, Eleftheria
AU - Bourboun, Nourxan
AU - Giannakoulas, George
AU - Balasubramanian, Meena
N1 - © 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
PY - 2022/11
Y1 - 2022/11
N2 - TAB2 is a gene located on chromosome 6q25.1 and plays a key role in development of the heart. Existing literature describes congenital heart disease as a common recognized phenotype of TAB2 gene variants, with evidence of a distinct syndromic phenotype also existing beyond this. Here we describe 14 newly identified individuals with nine novel, pathogenic TAB2 variants. The majority of individuals were identified through the Deciphering Developmental Disorders study through trio whole exome sequencing. Eight individuals had de novo variants, the other six individuals were found to have maternally inherited, or likely maternally inherited, variants. Five individuals from the same family were identified following cardiac disease gene panel in the proband and subsequent targeted familial gene sequencing. The clinical features of this cohort were compared to the existing literature. Common clinical features include distinctive facial features, growth abnormalities, joint hypermobility, hypotonia, and developmental delay. Newly identified features included feeding difficulties, sleep problems, visual problems, genitourinary abnormality, and other anatomical variations. Here we report 14 new individuals, including novel TAB2 variants, in order to expand the emerging syndromic clinical phenotype and provide further genotype-phenotype correlation.
AB - TAB2 is a gene located on chromosome 6q25.1 and plays a key role in development of the heart. Existing literature describes congenital heart disease as a common recognized phenotype of TAB2 gene variants, with evidence of a distinct syndromic phenotype also existing beyond this. Here we describe 14 newly identified individuals with nine novel, pathogenic TAB2 variants. The majority of individuals were identified through the Deciphering Developmental Disorders study through trio whole exome sequencing. Eight individuals had de novo variants, the other six individuals were found to have maternally inherited, or likely maternally inherited, variants. Five individuals from the same family were identified following cardiac disease gene panel in the proband and subsequent targeted familial gene sequencing. The clinical features of this cohort were compared to the existing literature. Common clinical features include distinctive facial features, growth abnormalities, joint hypermobility, hypotonia, and developmental delay. Newly identified features included feeding difficulties, sleep problems, visual problems, genitourinary abnormality, and other anatomical variations. Here we report 14 new individuals, including novel TAB2 variants, in order to expand the emerging syndromic clinical phenotype and provide further genotype-phenotype correlation.
KW - congenital heart disease
KW - developmental delay
KW - facial features
KW - joint hypermobility
KW - syndromal
KW - TAB2
KW - Heart Defects, Congenital/genetics
KW - Genetic Association Studies
KW - Humans
KW - Adaptor Proteins, Signal Transducing/genetics
KW - Developmental Disabilities/genetics
KW - Whole Exome Sequencing
KW - Intellectual Disability/genetics
KW - Phenotype
KW - Child
UR - http://www.scopus.com/inward/record.url?scp=85136083427&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.62949
DO - 10.1002/ajmg.a.62949
M3 - Journal article
C2 - 35971781
VL - 188
SP - 3331
EP - 3342
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
SN - 1552-4825
IS - 11
ER -